Expertise in
3
conditions

Yinzhong F. Shen

2901 Caolang Road, 
Shanghai, CN 
Expertise in
3
conditions
2901 Caolang Road, 
Shanghai, CN 

Overview

Yinzhong Shen practices practicing medicine in Shanghai, China.

Shen is highly rated in 3 conditions, according to our data. Their clinical expertise encompasses HIV/AIDS, Cryptococcosis, Severe Acute Respiratory Syndrome (SARS), and Cryptococcal Meningitis.

They are actively involved in clinical research, co-authoring 156 peer reviewed articles and participating in 2 clinical trials.

Locations

2901 Caolang Road, Shanghai, 201508, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicenter, Double-blind, Randomized, Placebo-Controlled, Phase II/III Study to Evaluate the Efficacy, Safety and Pharmacokinetics of JT001 (VV116) for the Early Treatment of Coronavirus Disease 2019 (COVID-19) in Participants With Mild to Moderate COVID-19.
A Multicenter, Double-blind, Randomized, Placebo-Controlled, Phase II/III Study to Evaluate the Efficacy, Safety and Pharmacokinetics of JT001 (VV116) for the Early Treatment of Coronavirus Disease 2019 (COVID-19) in Participants With Mild to Moderate COVID-19.
Enrollment Status: Terminated
Publish Date: September 22, 2023
Intervention Type: Drug
Study Drug: JT001
Study Phase: Phase 2/Phase 3
A Multi-center, Double-blinded, Randomized, Phase III Study to Evaluate the Efficacy and Safety of JT001 (VV116) Compared With Favipiravir in Participants With Moderate to Severe Coronavirus Disease 2019 (COVID-19)
A Multi-center, Double-blinded, Randomized, Phase III Study to Evaluate the Efficacy and Safety of JT001 (VV116) Compared With Favipiravir in Participants With Moderate to Severe Coronavirus Disease 2019 (COVID-19)
Enrollment Status: Terminated
Publish Date: February 08, 2023
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

156 Total Publications

Weight Gain Is Associated with Short-Term FIB-4 Increase and Concurrent Metabolic Change in People with HIV and Metabolic Dysfunction-Associated Steatotic Liver Disease.
Weight Gain Is Associated with Short-Term FIB-4 Increase and Concurrent Metabolic Change in People with HIV and Metabolic Dysfunction-Associated Steatotic Liver Disease.
Journal: Viruses
Published: July 04, 2026

Frequently Asked Questions about Yinzhong F. Shen

Is Yinzhong F. Shen a top-rated expert for HIV/AIDS?

MediFind is an objective health platform that identifies experts based on real-world data. Yinzhong F. Shen is classified as an Distinguished expert for HIV/AIDS, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Yinzhong F. Shen participate in research or clinical trials?

Yes. Yinzhong F. Shen has published 156 articles and abstracts on conditions like HIV/AIDS. You can view a list of Yinzhong F. Shen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Shen's expertise for a condition
ConditionClose
    View All 26 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile